S&P 500   3,097.05 (+0.33%)
DOW   27,723.21 (+0.11%)
QQQ   201.91 (+0.47%)
CGC   19.59 (-3.50%)
BABA   187.32 (+0.33%)
GE   11.56 (+1.85%)
T   39.25 (-0.30%)
F   9.12 (+0.44%)
ACB   3.63 (+0.28%)
PRI   129.93 (+0.54%)
BAC   33.27 (+0.27%)
DIS   139.17 (+1.77%)
S&P 500   3,097.05 (+0.33%)
DOW   27,723.21 (+0.11%)
QQQ   201.91 (+0.47%)
CGC   19.59 (-3.50%)
BABA   187.32 (+0.33%)
GE   11.56 (+1.85%)
T   39.25 (-0.30%)
F   9.12 (+0.44%)
ACB   3.63 (+0.28%)
PRI   129.93 (+0.54%)
BAC   33.27 (+0.27%)
DIS   139.17 (+1.77%)
Log in

Aimmune Therapeutics Earnings Date, Estimates & History (NASDAQ:AIMT)

$28.67
-0.15 (-0.52 %)
(As of 11/12/2019 11:46 AM ET)
Today's Range
$28.67
Now: $28.67
$29.28
50-Day Range
$20.53
MA: $25.17
$29.58
52-Week Range
$16.95
Now: $28.67
$31.83
Volume7,771 shs
Average Volume755,969 shs
Market Capitalization$1.80 billion
P/E RatioN/A
Dividend YieldN/A
Beta-0.03

Earnings

Aimmune Therapeutics (NASDAQ:AIMT) Earnings Information

Aimmune Therapeutics last posted its earnings data on November 6th, 2019. The biotechnology company reported ($1.03) earnings per share for the quarter, meeting the consensus estimate of ($1.03). Aimmune Therapeutics has generated ($3.67) earnings per share over the last year. Aimmune Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2020 based off prior year's report dates.

Aimmune Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Aimmune Therapeutics (NASDAQ:AIMT) Earnings Estimates

2019 EPS Consensus Estimate: ($3.45)
2020 EPS Consensus Estimate: ($3.11)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20192($0.91)($0.73)($0.82)
Q2 20192($0.90)($0.73)($0.82)
Q3 20192($0.92)($0.71)($0.82)
Q4 20192($1.04)($0.95)($1.00)
Q1 20202($0.95)($0.89)($0.92)
Q2 20202($0.86)($0.85)($0.86)
Q3 20202($0.78)($0.73)($0.76)
Q4 20202($0.62)($0.53)($0.58)
Q1 20211($0.48)($0.48)($0.48)
Q2 20211($0.35)($0.35)($0.35)
Q3 20211($0.20)($0.20)($0.20)

Aimmune Therapeutics (NASDAQ AIMT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/27/2020
(Estimated)
       
11/6/2019Q3($1.03)($1.03)($1.03)Transcript
8/8/2019Q2 2019($0.93)($1.0088)($1.01)Listen
5/8/20193/31/2019($0.94)($0.87)($0.87)Listen
2/28/2019Q4 2018($0.84)($0.95)($0.95)N/A
11/8/2018Q3($0.92)($0.89)($0.89)N/A
8/8/2018Q2 2018($0.86)($0.91)($0.91)N/A
5/8/2018Q1 2018($0.7110)($0.9240)($0.92)N/A
3/12/2018Q4 2017($0.72)($0.81)($0.81)N/A
11/6/2017Q3 2017($0.72)($0.63)($0.63)N/A
8/8/2017Q2($0.64)($0.65)($0.65)N/A
5/8/2017Q1 2017($0.57)($0.52)($0.52)N/A
3/15/2017Q4 2016($0.47)($0.55)($0.55)N/A
11/14/2016Q3 2016($0.4460)($0.53)($0.53)N/A
8/10/2016Q216($0.42)($0.43)($0.43)N/A
5/16/2016Q116($0.40)($0.37)($0.37)N/A
3/3/2016Q415($0.35)($0.39)($0.39)Listen
11/4/2015Q3 2015($0.24)($0.36)($0.36)N/A
8/31/2015Q2 2015($1.60)($1.60)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/12/2019 by MarketBeat.com Staff

Featured Article: Day Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel